Intentional overdose of Large Animal Immobilon

European Journal of Emergency Medicine

Volumn 11, Issue 5, 2004, Pages 298-301

  Sterken, Joeri ^a   Troubleyn, Joris ^a   Gasthuys, Frank ^a   Maes, Viviane ^a   Diltoer, Mark ^a   Verborgh, Christian ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Analgesics; Antagonists; Diprenorphine; Etorphine; Keywords; Naloxone; Opioid

Indexed keywords

ETORPHINE; IMMOBILON; LEVOMEPROMAZINE;

ADULT; APACHE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CRITICAL ILLNESS; DISEASE COURSE; DRUG COMBINATION; EMERGENCY HEALTH SERVICE; FATALITY; FEMALE; GLASGOW COMA SCALE; HEART ARREST; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; RESUSCITATION; REVIEW; SUICIDE ATTEMPT;

ADULT; APACHE; CARDIOPULMONARY RESUSCITATION; COMBINED MODALITY THERAPY; CRITICAL ILLNESS; DISEASE PROGRESSION; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ETORPHINE; FATAL OUTCOME; FEMALE; GLASGOW COMA SCALE; HEART ARREST; HUMANS; METHOTRIMEPRAZINE; SUICIDE, ATTEMPTED; TRIAGE;

EID: 16644395338     PISSN: 09699546     EISSN: 14735695     Source Type: Journal    
DOI: 10.1097/00063110-200410000-00013     Document Type: Article

References (29)

1. Blane GF, Boura AL, Fitzgerald AE, Lister RE. Actions of etorphine hydrochloride, (M99): a potent morphine-like agent. Br J Pharmacol 1967; 30:11-22.
2. Dobbs HE. Effects of cyprenorphine (M285), a morphine antagonist, on the distribution and excretion of etorphine (M99), a potent morphine-like drug. J Pharmacol Exp Ther 1968; 160:407-414.
3. Buss PE, Meltzer DG. Changes in respiratory function following the intramuscular administration of etorphine to Boer goats (Capra hircus). J S Afr Vet Assoc 2001; 72:137-142.
4. Stegmann GF. Etorphine-halothane anaesthesia in two five-year-old African elephants (Loxodonta africana). J S Afr Vet Assoc 1999; 70:164-166.
5. Ramsay EC, Loomis MR, Mehren KG, Boardman WS, Jensen J, Geiser D. Chemical restraint of the Nile hippopotamus (Hippopotamus amphibius) in captivity. J Zoo Wildlife Med 1998; 29:45-49.
6. Meulemans A, Van den Berghe G, Winnen B, Delooz H. Gastrointestinal decontamination for acute poisoning. Acta Clin Belg 1990; 13(Suppl.):13-19.
7. Stowell LI. Suicide with the veterinary drug acepromazine. J Anal Toxicol 1998; 22:166-168.
8. Elliott SP, Hale KA. Analysis of etorphine in postmortem samples by HPLC with UV diode-array detection. Forens Sci Int 1999; 101:9-16.
9. No authors listed. Immobilon: curiously strong. Lancet 1977; 310:178.
10. Blane GF, Robbie DS. Trial of etorphine (M99 Reckitt) in carcinoma pain: preliminary report. Br J Pharmacol 1970; 39:252P-253P.
11. Volans GN, Whittle BA. Accidental injection of immobilon [Letter]. BMJ 1976; 2:472-473.
12. Goodrich PG. Accidental self-injection. Veterinary Rec 1977; 100:458-459.
13. Orr CM. Accidental self-injection. Veterinary Rec 1977; 100:574.
14. Firn S. Accidental poisoning by an animal-immobilising agent. Lancet 1973; 302:95-96.
15. Ngai SH, Berkowitz BA, Yang JC, Hempstead J, Spector S. Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action. Anesthesiology 1976; 44:398-401.
16. Berkowitz BA, Ngai SH, Hempstead J, Spector S. Disposition of naloxone: use of a new radioimmunoassay. J Pharmacol Exp Ther 1975; 195:499-504.
17. DeRossett SE, Holtzman SG. Effects of naloxone, diprenorphine, buprenorphine and etorphine on unpunished and punished food-reinforced responding in the squirrel monkey. J Pharmacol Exp Ther 1984; 228:669-675.
18. Tremblay E, Colombel MC, Jacob J. Precipitation and prevention of abstinence in acutely morphinized rats and mice: comparisons between naloxone, naltrexone, and diprenorphine. Psychopharmacology (Berl) 1976; 49:41-48.
19. Paul D, Pick CG, Tive LA, Pasternak GW. Pharmacological characterization of nalorphine, a kappa 3 analgesic. J Pharmacol Exp Ther 1991; 257:1-7.
20. Grabus SD, Smurthwaite ST, Riley AL. Nalorphine’s ability to substitute for morphine in a drug discrimination procedure is a function of training dose. Pharmacol Biochem Behav 1999; 63:481-488.
21. Quillan JM, Carlson KW, Song C, Wang D, Sadee W. Differential effects of mu-opioid receptor ligands on Ca(2+) signaling. J Pharmacol Exp Ther 2002; 302:1002-1012.
22. Bot G, Blake AD, Li S, Reisine T. Mutagenesis of a single amino acid in the rat mu-opioid receptor discriminates ligand binding. J Neurochem 1998; 70:358-365.
23. Rodriguez FD, Bardaji E, Traynor JR. Differential effects of Mg2+ and other divalent cations on the binding of tritiated opioid ligands. J Neurochem 1992; 59:467-472.
24. Melichar JK, Nutt DJ, Malizia AL. Naloxone displacement at opioid receptor sites measured in vivo in the human brain. Eur J Pharmacol 2003; 459:217-219.
25. Lee KO, Akil H, Woods JH, Traynor JR. Differential binding properties of oripavines at cloned mu- and delta-opioid receptors. Eur J Pharmacol 1999; 378:323-330.
26. Berns SD, Wright JL. Pediatric acepromazine poisoning: the importance of child-resistant packaging for veterinary drugs. Am J Emerg Med 1993; 11:247-248.
27. Clutton RE. Attempted suicide with acepromazine maleate: a case report. Vet Hum Toxicol 1985; 27:391.
28. Schmidt W, Lang K. Life-threatening dysrhythmias in severe thioridazine poisoning treated with physostigmine and transient atrial pacing. Crit Care Med 1997; 25:1925-1930.
29. Manzanares J, Corchero J, Romero J, Fernandez-Ruiz JJ, Ramos JA, Fuentes JA. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 1999; 20:287-294.